Pseudoxanthoma elasticum (PXE), or Grönblad-Strandberg syndrome, is an autosomal-recessive, or sometimes autosomaldominant, genetic disease that causes fragmentation and calcification of arterial elastic fibers in certain tissues. The skin, eyes, and blood vessels are prominently involved, and with increasing age, a premature form of atherosclerosis develops. PXE commonly affects the skin even in early childhood. Later, yellowish papular lesions form and cutaneous laxity affects the neck, axillae (armpits), groin, the inside parts of the elbows, and knees. Careful inspection of the axillae is helpful in establishing the diagnosis (Fig. 1a) , coupled with a detailed funduscopic examination of the eye (Fig. 1b) . PXE affects the retina through a dimpling of Bruch's membrane, which separates the blood vessel-rich layer of the retina from the pigmented layer. Breaks or cracks in Bruch's membrane create typical "angioid" streaks radiating from the optic nerve. Blood vessels penetrating Bruch's membrane may hemorrhage, thereby compromising vision. The principal clinical complaints involve the gastrointestinal tract and cardiovascular systems. Upper gastrointestinal bleeding may develop. However, the circulatory system is more commonly involved and intermittent claudication is a prominent feature. At later stages, coronary artery disease occurs, leading to angina pectoris and myocardial infarction at an early age [1] . Patients with clinical PXE have mutations in the ABCC6 gene, encoding the multidrug resistance protein 6, an ATP-binding cassette subfamily C member also known as ABCC6. ABCC6 is the multispecific organic anion transporter E [2, 3] . The most common mutations, R1141X and 23-29del, represent about a quarter of the mutations in ABCC6 [4, 5] .
ABC transporters are transmembrane proteins that utilize the energy of adenosine triphosphate (ATP) hydrolysis to carry out certain biological processes including translocation of various substrates across membranes and non-transport-related processes such as translation of RNA and DNA repair. The transported substrates include metabolic products, lipids and sterols, and drugs. ABC transporters are involved in tumor resistance, cystic fibrosis, and a range of other inherited human diseases along with both bacterial (prokaryotic) and eukaryotic (including human) development of resistance to multiple drugs. Interestingly, mutations in ABCC6 are associated with premature atherosclerosis, even in patients without PXE [6] . However, the function of ABCC6 and how the mutations lead to the phenotype is unknown [7] .
In this issue, Guo and colleagues present their data on Abcc6 gene-deleted (−/−) mice [8] . These mice develop extensive mineralization of the arterial tree and disturbances in Bruch's membrane very similar to those observed in PXE. The authors found that by age 12 weeks, the Abcc6 −/− mice had increased total cholesterol and triglyceride plasma concentrations. Treatment of the mice with atorvastatin at low (0.01 % of diet weight) and high (0.4 % of diet weight) doses beginning at age 4 weeks reduced lipid values and also ameliorated vascular calcification, particularly at the higher dose, whereas beginning treatment at 12 weeks, when calcification had already occurred, was not helpful. Guo et al. estimate that the higher dose of atorvastatin would be equivalent to about 110 mg/day in humans [8] . The higher dose of atorvastatin reduced triglycerides by about 50 % and cholesterol about 27 %. The control mice had total cholesterol of about 80 mg/dl, while triglycerides were about 50 mg/dl. Abcc6 . This result could be related to reduced prenylation of RhoA in response to statins [9] . Such a mechanism could have been operative in the Abcc6 −/− mice.
Future experiments investigating the effects of atorvastatin on the functions of ABCC6 are needed. The protein is largely expressed in the liver and the kidney, so that the vascular effects of gene deletion are surprising. ABCC6 resides in the basolateral plasma membrane of hepatocytes, mediating the sinusoidal efflux of unknown metabolites from the hepatocytes to the systemic circulation [10] . A recent study has also suggested a role of endoplasmic reticulum chaperones in cellular trafficking [11] . The findings of Guo et al. [8] are interesting; however, further studies are necessary to provide mechanistic answers. 
